Xenon Pharmaceuticals (XENE) Return on Capital Employed Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 68,255.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 2,665.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 31,429.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 2,503.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -105.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 2,400.00 |
| 10 | Xenon Pharmaceuticals | 4.78 Bn | 4.78 Bn | - | -287.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -287.00 |
| Dec 31, 2025 | -2,872.00 |
| Sep 30, 2025 | -2,576.00 |
| Jun 30, 2025 | -1,978.00 |
| Mar 31, 2025 | -1,530.00 |
| Dec 31, 2024 | -867.00 |
| Sep 30, 2024 | 41.00 |
| Jun 30, 2024 | 31.00 |
| Mar 31, 2024 | -185.00 |
| Dec 31, 2023 | -967.00 |
| Sep 30, 2023 | -2,436.00 |
| Jun 30, 2023 | -2,306.00 |
| Mar 31, 2023 | -1,845.00 |
| Dec 31, 2022 | -1,212.00 |
| Sep 30, 2022 | 1,018.00 |
| Jun 30, 2022 | 955.00 |
| Mar 31, 2022 | 289.00 |
| Dec 31, 2021 | -89.00 |
| Sep 30, 2021 | -1,785.00 |
| Jun 30, 2021 | -1,526.00 |
| Mar 31, 2021 | -173.00 |
| Dec 31, 2020 | 968.00 |
| Sep 30, 2020 | 4,460.00 |
| Jun 30, 2020 | 4,567.00 |
| Mar 31, 2020 | 3,223.00 |
| Dec 31, 2019 | 1,704.00 |
| Sep 30, 2019 | -350.00 |
| Jun 30, 2019 | 2,166.00 |
| Mar 31, 2019 | 4,745.00 |
| Dec 31, 2018 | 4,617.00 |
| Dec 31, 2017 | -4,014.00 |
| Dec 31, 2016 | -2,254.00 |
| Sep 30, 2016 | -2,636.00 |
| Jun 30, 2016 | -3,202.00 |
| Mar 31, 2016 | -2,077.00 |
| Dec 31, 2015 | -3,425.00 |